Literature DB >> 19787627

The expression and significance of Dickkopf-1 in epithelial ovarian carcinoma.

Wang Shizhuo1, Jiang Tao, Zhang Shulan, Zhang Bing.   

Abstract

The aim of this study was to investigate the presence and prognostic value of Dickkopf-1 (DKK1) in epithelia ovarian carcinoma. The expression of DKK1 was determined in 56 epithelial ovarian carcinoma tissues, 35 benign ovarian cystadenoma tissues, and 12 normal ovarian tissues by quantitative real-time PCR and immunohistochemistry. The DKK1 mRNA level in the carcinoma tissues was upregulated (5.5+/-2.7-fold increase) compared with that in the normal tissues (p<0.0001). The mRNA level of DKK1 in the cystadenoma tissues (1.1+/-0.4-fold increase) was not statistically different from that in the normal tissues (p=0.486). DKK1 protein expression in the carcinoma tissues was also higher (89.29%) than in cystadenoma (65.71%) and normal tissues (58.33%) (p=0.006 and p=0.009, respectively). In epithelial ovarian carcinoma, DKK1 gene and protein overexpression was associated with advanced FIGO stage (p=0.007, p=0.004) and poor differentiation grade (p=0.027, p=0.010). Elevated DKK1 protein levels in ovarian carcinoma samples were associated with a poor outcome in univariate and multivariate analysis (p<0.0001 and p<0.0001, respectively). The study indicated that DKK1 maymbe a useful prognostic and diagnostic indicator for epithelial ovarian carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787627     DOI: 10.1177/172460080902400306

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   3.248


  11 in total

1.  Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion.

Authors:  Shizhuo Wang; Shulan Zhang
Journal:  Clin Exp Metastasis       Date:  2011-05-24       Impact factor: 5.150

2.  Prognostic significance of dickkopf-1 overexpression in solid tumors: a meta-analysis.

Authors:  Yanqiong Liu; Weizhong Tang; Li Xie; Jian Wang; Yan Deng; Qiliu Peng; Limin Zhai; Shan Li; Xue Qin
Journal:  Tumour Biol       Date:  2013-11-21

3.  Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy.

Authors:  J A Wall; S Meza-Perez; C B Scalise; A Katre; A I Londoño; W J Turbitt; T Randall; L A Norian; R C Arend
Journal:  Gynecol Oncol       Date:  2020-11-07       Impact factor: 5.304

4.  Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions.

Authors:  Anita Monika Chudecka-Głaz; Aneta Alicja Cymbaluk-Płoska; Janusz Leszek Menkiszak; Ewa Pius-Sadowska; Bogusław Bronisław Machaliński; Agnieszka Sompolska-Rzechuła; Izabella Anna Rzepka-Górska
Journal:  Onco Targets Ther       Date:  2015-02-23       Impact factor: 4.147

Review 5.  Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

Authors:  Michael H Kagey; Xi He
Journal:  Br J Pharmacol       Date:  2017-07-07       Impact factor: 8.739

6.  Dickkopf-4 is frequently overexpressed in epithelial ovarian carcinoma and promotes tumor invasion.

Authors:  Shizhuo Wang; Heng Wei; Shulan Zhang
Journal:  BMC Cancer       Date:  2017-06-30       Impact factor: 4.430

7.  Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment.

Authors:  Florian Finkernagel; Silke Reinartz; Maximiliane Schuldner; Alexandra Malz; Julia M Jansen; Uwe Wagner; Thomas Worzfeld; Johannes Graumann; Elke Pogge von Strandmann; Rolf Müller
Journal:  Theranostics       Date:  2019-08-22       Impact factor: 11.556

8.  Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma.

Authors:  Seung Up Kim; Jeon Han Park; Hyon-Suk Kim; Jae Myun Lee; Hyun Gyu Lee; Hyemi Kim; Sung Hoon Choi; Shinhwa Baek; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Jong Doo Lee; Kwang-Hyub Han
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

9.  Mutation or loss of p53 differentially modifies TGFβ action in ovarian cancer.

Authors:  Eoghainín Ó hAinmhire; Suzanne M Quartuccio; Whay Cheng; Roshan A Ahmed; Shelby M King; Joanna E Burdette
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

10.  Serum dickkopf-1 as a clinical and prognostic factor in non-small cell lung cancer patients with bone metastases.

Authors:  Rong Qiao; Runbo Zhong; Qing Chang; Jiajun Teng; Jun Pei; Baohui Han; Tianqing Chu
Journal:  Oncotarget       Date:  2017-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.